Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
72.09
+0.22 (0.31%)
May 1, 2024, 12:23 PM EDT - Market open
Boston Scientific Revenue
In the year 2023, Boston Scientific had annual revenue of $14.24B with 12.29% growth. Revenue in the quarter ending December 31, 2023 was $3.73B with 14.90% year-over-year growth.
Revenue (ttm)
$14.24B
Revenue Growth
+12.29%
P/S Ratio
7.42
Revenue / Employee
$296,667
Employees
48,000
Market Cap
105.99B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | 10.74B | 912.00M | 9.28% |
Dec 31, 2018 | 9.82B | 775.00M | 8.57% |
Dec 31, 2017 | 9.05B | 662.00M | 7.89% |
Dec 31, 2016 | 8.39B | 909.00M | 12.16% |
Dec 31, 2015 | 7.48B | 97.00M | 1.31% |
Dec 31, 2014 | 7.38B | 237.00M | 3.32% |
Dec 31, 2013 | 7.14B | -106.00M | -1.46% |
Dec 31, 2012 | 7.25B | -373.00M | -4.89% |
Dec 31, 2011 | 7.62B | -184.00M | -2.36% |
Dec 31, 2010 | 7.81B | -382.00M | -4.67% |
Dec 31, 2009 | 8.19B | 138.00M | 1.71% |
Dec 31, 2008 | 8.05B | -307.00M | -3.67% |
Dec 31, 2007 | 8.36B | 536.00M | 6.85% |
Dec 31, 2006 | 7.82B | 1.54B | 24.48% |
Dec 31, 2005 | 6.28B | 659.00M | 11.72% |
Dec 31, 2004 | 5.62B | 2.15B | 61.80% |
Dec 31, 2003 | 3.48B | 557.00M | 19.08% |
Dec 31, 2002 | 2.92B | 246.00M | 9.20% |
Dec 31, 2001 | 2.67B | 9.00M | 0.34% |
Dec 31, 2000 | 2.66B | -178.00M | -6.26% |
Dec 31, 1999 | 2.84B | 608.00M | 27.22% |
Dec 31, 1998 | 2.23B | 403.00M | 22.01% |
Dec 31, 1997 | 1.83B | 279.76M | 18.03% |
Dec 31, 1996 | 1.55B | 360.42M | 30.27% |
Dec 31, 1995 | 1.19B | 302.25M | 34.02% |
Dec 31, 1994 | 888.57M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CVS Health | 357.78B |
Cigna | 195.27B |
Elevance Health | 171.75B |
Sanofi | 51.60B |
Bristol-Myers Squibb Company | 45.53B |
Medtronic | 32.32B |
Stryker | 20.50B |
Regeneron Pharmaceuticals | 13.12B |
BSX News
- 7 days ago - Boston Scientific Beats Forecasts, Boosts Outlook on Booming Heart Device Sales - Investopedia
- 7 days ago - Boston Scientific Stock Rises on More Than Just an Earnings Beat - Barrons
- 7 days ago - Boston Scientific raises annual profit forecast on strong demand for heart devices - Reuters
- 7 days ago - Boston Scientific's stock jumps 2.7% after earnings top estimates - Market Watch
- 7 days ago - Boston Scientific Announces Results for First Quarter 2024 - PRNewsWire
- 13 days ago - FDA classifies recall of Boston Scientific device to treat hemorrhaging as 'most serious' - Reuters
- 23 days ago - Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module - PRNewsWire
- 27 days ago - FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal - Reuters